Predictive Oncology Inc (POAI) USD0.01
Predictive Oncology Inc. is a data and artificial intelligence (AI)-driven discovery services company. The Company provides predictive models of tumor drug response that are used to improve clinical outcomes for patients. It operates through three segments: Helomics, Skyline and Soluble. Helomics segment includes clinical testing and contract research services that include the application of AI. Soluble segment provides services using a self-contained, automated system that conducts throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. Skyline segment consists of the STREAMWAY System product sales. Its three primary business areas includes application of AI, production of system for automated, direct-to-drain medical fluid disposal and associated products, and contract services and research.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.